Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

CNL Healthcare Properties (CHTH) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for CNL Healthcare Properties (CHTH) over the last 14 years, with Q3 2025 value amounting to 22.49%.

  • CNL Healthcare Properties' EBITDA Margin rose 1400.0% to 22.49% in Q3 2025 from the same period last year, while for Sep 2025 it was 22.19%, marking a year-over-year increase of 9100.0%. This contributed to the annual value of 22.27% for FY2024, which is 36000.0% up from last year.
  • Latest data reveals that CNL Healthcare Properties reported EBITDA Margin of 22.49% as of Q3 2025, which was up 1400.0% from 23.37% recorded in Q2 2025.
  • CNL Healthcare Properties' EBITDA Margin's 5-year high stood at 24.91% during Q2 2024, with a 5-year trough of 4.63% in Q4 2021.
  • For the 5-year period, CNL Healthcare Properties' EBITDA Margin averaged around 19.65%, with its median value being 20.7% (2024).
  • In the last 5 years, CNL Healthcare Properties' EBITDA Margin crashed by -133000bps in 2021 and then soared by 116800bps in 2022.
  • Quarter analysis of 5 years shows CNL Healthcare Properties' EBITDA Margin stood at 4.63% in 2021, then skyrocketed by 252bps to 16.31% in 2022, then grew by 1bps to 16.46% in 2023, then rose by 26bps to 20.7% in 2024, then grew by 9bps to 22.49% in 2025.
  • Its last three reported values are 22.49% in Q3 2025, 23.37% for Q2 2025, and 22.13% during Q1 2025.